233 related articles for article (PubMed ID: 11406571)
21. Identification of H, K, and N-ras point mutations in stage IB cervical carcinoma.
Grendys EC; Barnes WA; Weitzel J; Sparkowski J; Schlegel R
Gynecol Oncol; 1997 May; 65(2):343-7. PubMed ID: 9159349
[TBL] [Abstract][Full Text] [Related]
22. Characterization of p53 mutations in colorectal liver metastases and correlation with clinical parameters.
Tullo A; D'Erchia AM; Honda K; Mitry RR; Kelly MD; Habib NA; Saccone C; Sbisà E
Clin Cancer Res; 1999 Nov; 5(11):3523-8. PubMed ID: 10589767
[TBL] [Abstract][Full Text] [Related]
23. Point mutations in both transforming and non-transforming codons of the N-ras proto-oncogene of Ph+ leukemias.
Rovera G; Reichard BA; Hudson S; Bittenbender S; Yamada M; Tournay O; Preisler HD
Oncogene; 1989 Jul; 4(7):867-72. PubMed ID: 2666907
[TBL] [Abstract][Full Text] [Related]
24. K-ras mutational analysis of polyclonal colorectal cancers identifies uniclonal circulating tumor cells.
Thebo JS; Senagore AJ; Krygier S; Luchtefeld MA
Am Surg; 2001 Aug; 67(8):802-5. PubMed ID: 11510588
[TBL] [Abstract][Full Text] [Related]
25. [Detection of K-ras gene mutations in DNA extracted from the plasma of patients with pancreatic cancer].
Feng D; Han T; Jiang Y; Yuan Z; Wang X; Jiang Z; Zhang S
Zhonghua Wai Ke Za Zhi; 2000 Oct; 38(10):767-70. PubMed ID: 11832160
[TBL] [Abstract][Full Text] [Related]
26. [Low incidence of point mutation of N-ras oncogene in human gliomas].
Tsurushima H; Ohno T; Tsuboi K; Yoshii Y; Meguro K; Nose T
No Shinkei Geka; 1995 Jul; 23(7):581-6. PubMed ID: 7637839
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of RAS point mutations in papillary thyroid carcinoma; a novel mutation at codon 31 of K-RAS.
Cyniak-Magierska A; Brzeziańska E; Januszkiewicz-Caulier J; Jarzab B; Lewiński A
Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):594-9. PubMed ID: 17943694
[TBL] [Abstract][Full Text] [Related]
28. Detection of point mutations at codon 12 of KI-ras in ophthalmic pterygia.
Detorakis ET; Zafiropoulos A; Arvanitis DA; Spandidos DA
Eye (Lond); 2005 Feb; 19(2):210-4. PubMed ID: 15232598
[TBL] [Abstract][Full Text] [Related]
29. H-ras-1 point mutations in soft tissue sarcomas.
Wilke W; Maillet M; Robinson R
Mod Pathol; 1993 Mar; 6(2):129-32. PubMed ID: 8483882
[TBL] [Abstract][Full Text] [Related]
30. Human malignant melanoma: detection of BRAF- and c-kit-activating mutations by high-resolution amplicon melting analysis.
Willmore-Payne C; Holden JA; Tripp S; Layfield LJ
Hum Pathol; 2005 May; 36(5):486-93. PubMed ID: 15948115
[TBL] [Abstract][Full Text] [Related]
31. The balanced induction of K-ras codon 12 and 13 mutations in mucosa differs from their ratio in neoplastic tissues.
Kraus MC; Seelig MH; Linnemann U; Berger MR
Int J Oncol; 2006 Oct; 29(4):957-64. PubMed ID: 16964391
[TBL] [Abstract][Full Text] [Related]
32. ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer.
Garcia-Rostan G; Zhao H; Camp RL; Pollan M; Herrero A; Pardo J; Wu R; Carcangiu ML; Costa J; Tallini G
J Clin Oncol; 2003 Sep; 21(17):3226-35. PubMed ID: 12947056
[TBL] [Abstract][Full Text] [Related]
33. H-ras oncogene mutation in dedifferentiated chondrosarcoma: polymerase chain reaction-restriction fragment length polymorphism analysis.
Sakamoto A; Oda Y; Adachi T; Oshiro Y; Tamiya S; Tanaka K; Matsuda S; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2001 Apr; 14(4):343-9. PubMed ID: 11301351
[TBL] [Abstract][Full Text] [Related]
34. Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines.
Bloethner S; Chen B; Hemminki K; Müller-Berghaus J; Ugurel S; Schadendorf D; Kumar R
Carcinogenesis; 2005 Jul; 26(7):1224-32. PubMed ID: 15760917
[TBL] [Abstract][Full Text] [Related]
35. A modified mutagenic PCR-RFLP method for K-ras codon 12 and 13 mutations detection in NSCLC patients.
Hatzaki A; Razi E; Anagnostopoulou K; Iliadis K; Kodaxis A; Papaioannou D; Labropoulos S; Vasilaki M; Kosmidis P; Saetta A; Mihalatos M; Nasioulas G
Mol Cell Probes; 2001 Oct; 15(5):243-7. PubMed ID: 11735295
[TBL] [Abstract][Full Text] [Related]
36. Quantitative detection of mutant alleles of the K-ras gene with minor groove binder-conjugated fluorogenic DNA probes.
Itabashi T; Maesawa C; Uchiyama M; Higuchi T; Masuda T
Int J Oncol; 2004 Mar; 24(3):687-96. PubMed ID: 14767554
[TBL] [Abstract][Full Text] [Related]
37. Identification of mutations in the Ki-ras gene in human retinoblastoma.
Bautista D; Emanuel JR; Granville C; Howard R; Costa J
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2313-7. PubMed ID: 8843915
[TBL] [Abstract][Full Text] [Related]
38. Detection of K-ras mutations in resected primary leiomyosarcoma.
Hill MA; Gong C; Casey TJ; Menon AG; Mera R; Gillespie AT; Giardina JF; Levine EA; Hunt JD
Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):1095-100. PubMed ID: 9419409
[TBL] [Abstract][Full Text] [Related]
39. Analysis of BRAF and N-RAS mutations in metastatic melanoma tissues.
Gorden A; Osman I; Gai W; He D; Huang W; Davidson A; Houghton AN; Busam K; Polsky D
Cancer Res; 2003 Jul; 63(14):3955-7. PubMed ID: 12873990
[TBL] [Abstract][Full Text] [Related]
40. Expression status and mutational analysis of the ras and B-raf genes in ovarian granulosa cell and epithelial tumors.
Jamieson S; Alexiadis M; Fuller PJ
Gynecol Oncol; 2004 Dec; 95(3):603-9. PubMed ID: 15581971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
